echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Two funds were set up to escort the development of biomedical industry in Bohai New Area

    Two funds were set up to escort the development of biomedical industry in Bohai New Area

    • Last Update: 2019-10-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends 】Recently, Cangzhou Bohai New Area Chuangxing biomedical venture Co., Ltd (hereinafter referred to as "Chuangxing pharmaceutical fund") with a scale of 100 million yuan and Cangzhou Bohai New Area Chuangxing hi tech biomedical partnership (limited partnership) (hereinafter referred to as "venture capital pharmaceutical fund") with a scale of 20.3 million yuan have been successfully established in the port economic development zone of Cangzhou Bohai new area to inject new life into the development of biomedical industry in Bohai new area Energy It is reported that these two funds are mainly invested in seed and start-up enterprises in the economic development zone of Lingang, and help start-ups of scientific and technological enterprises and serve the transformation of scientific and technological achievements Among them, "Chuangxing pharmaceutical fund" has a business term of 7 years, mainly serving biomedicine, new materials, fine chemicals and other industries in Bohai new area; and "Chuangtou pharmaceutical fund" has a business term of 5 years, mainly serving small and medium-sized scientific and technological enterprises in seed stage and start-up stage and high-tech enterprises in line with the key support of the state The two funds will enable Bohai new area to better undertake the industrial transfer from Beijing, Tianjin and Hebei, attract high-tech industries and high-tech enterprises to land and develop, and play an important role in cultivating and expanding the biomedical industry This Spring Festival, with Tianjin Pharmaceutical Group, Zhengda Pharmaceutical Group - ted pharmaceutical, Shijiazhuang No.4 pharmaceutical, Beijing Xiehe Pharmaceutical Co., Ltd., China Resources Shuanghe, Zhongguancun Science and technology - HuaSu pharmaceutical, wholly owned by the United States - fabergin and other strength enterprises entering the biomedical industrial park in Bohai new area, it means that the curtain of high-quality development has been opened The park is located in the "port economic and Technological Development Zone", and the projects entering the Zone enjoy the relevant preferential policies of the development zone It is reported that in order to further promote the high-quality development of the biomedical industry in the park, the biomedical industry park in Bohai new area will focus on "new drug research and development, pharmaceutical preparations, Apis" based on the regional industrial positioning , medical devices, health products, contract customization services and other key pharmaceutical and big health industries "launched investment promotion, constantly accumulated leading biomedical enterprises, and built a demonstration park for coordinated development of Beijing, Tianjin and Hebei On July 23 this year, at the meeting of the Party Working Committee (expansion) of Cangzhou port economic and Technological Development Zone, it was proposed that in the second half of the year, the tasks of Cangzhou Bohai new area port economic and Technological Development Zone should be clearly defined To achieve high-quality development, high-quality projects must be supported We should firmly adhere to the new development concept, seize the opportunity of the transfer of chemical enterprises in surrounding provinces, introduce high-quality chemical enterprises, do a good job in extending the industrial chain, actively expand cooperation with universities, and improve the scientific and technological content of projects At the same time, we must create a high-quality industrial ecology We need to strengthen the construction of upstream and downstream comprehensive supporting industries, expand from single projects to industrial clusters, and strengthen the comprehensive services of finance, fund, medical treatment and education around the development of green petrochemical, biomedicine and large health industries In recent years, the biomedical industry in Bohai new area has been developing and growing, with a good momentum of low energy consumption, low emissions, benefits and high quality Among them, Cangzhou Lingang Economic Development Zone ranks among the "top 20 chemical industry parks in China" for six consecutive years, ranks among the 100 billion level economic and technological development zones, and becomes the province's top development zone In addition, the Ministry of industry and information technology of the people's Republic of China released the fourth batch of green manufacturing list this year, and Cangzhou Bohai new area port economic and Technological Development Zone was successfully selected into the list of green parks.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.